½ðÄê»á

À´Ô´£º½»ÓÑÂÛ̳ £¬×÷Õߣº £¬£º

ÚÀ £¬ÎÒ¸úÄ㽲࣠£¬×î½ü°¡ £¬¸÷È˶¼Âù°®ÎÊÒ»¸öÎÊÌ⣺ÏÃÃźóϪ½ÖÓÐÄêÇáµÄÂð£¿Äã½²ÊÇûÊÇ £¬Õâ¸öÎÊÌâÌýÆðÀ´ÏñÊÇÎÊÌìÆø £¬ÊµÔò±ðÓÐǬÀ¤¡£ÉÏ»ØÎÒÔÚ²è�ÀïÌý¼¸¸öÀÏ»ï¼Æ³¶°å· £¬ËûÃÇ»¹½²µ½Õâ¸ö½Ö £¬½²µÃÊÇÓеãÒâ˼¡£

ºóϪ½ÖµÄ¡°ÃŵÀ¡± £¬ÄãÏþµÃ¼¸·Ö¿©£¿

Ïà¹ØÍ¼Æ¬

ÄãÒªÊÇÊ״ο˺óϪ½Ö £¬¿ÉÄܾ;õµÃÕâÌõ½ÖÂï £¬ÀϾɡ¢Õ­ £¬ÃÅÁ³×Ó¶¼Ã»µÃɶ×ÓÐÂÏʸС£ÄêÇáÈËÊDz»ÊÇÂùÉÙ£¿È·Êµ £¬ÕâµØ·½ÒÔ¡°ÀÏζµÀ¡±×ÅÃû £¬ÊǸö²Ø¹Êʵĵط½¡£ÎÒÄêÇá×ÓÄÇ¿­ £¬È¥¹ýÏÃÃÅ·¢ñ² £¬ºóϪ½Ö»¹Ã»ÏÖÔÚÕâÑùÈÈÄÖ £¬½ÖÍ·ÏïβȫÊÇÂôÀÏÏÃÃÅС³ÔµÄ̯×Ó £¬ÄÇζµÀµõµÃÄãÂúÄԿǶ¼ÊÇ¡£

²»¹ý £¬±ð¿´ËüÍâòÀÏÆø £¬Êµ¼ÊÉÏÕâ½ÖÊÇÓÐÁ½²ãÊÀ½çµÄ¡£Ò»²ãÊǰÚÔÚÃ÷ÃæÉ쵀 £¬Âô³ÔµÄ¡¢Âô¾ÉÎï¼þµÄ £¬Âù¶àÓοͿ˴ò¿¨£»ÁíÒ»²ãÂï £¬ºÙºÙ £¬²ØÔÚÄÇЩ²»ÆðÑÛµÄСÏï×ÓÀïÍ· £¬ÄÇÀï²ÅÊǺóϪ½ÖµÄÁé»ê¡£ÄãÏþµÃ²» £¬ÕæÕý¶®ºóϪ½ÖµÄÄêÇáÈË £¬¶¼ÊÇÍùÏï×ÓÉî´¦×ê £¬È¥ÕÒÄÇЩСÖÚ¿§·Èµê¡¢ÊÖ¹¤ÒÕ·» £¬ÁíÓÐһЩС¾Æ¹Ý¡£

Ïà¹ØÍ¼Æ¬
͵͵¸æËßÄã࣠£¬ÒªÔÚºóϪ½ÖÕÒÄêÇáÈË £¬¾ÍÒª¶¢×¡ÄÇÖÖÃÅÁ³²»ÆðÑÛµ«´°×Ó͸³öůµÆ¹âµÄСµê¡£ÄÇЩµØ·½Ò»°ãûµÃÃ÷»Î»ÎµÄÕÐÅÆ £¬µ«Ö»ÒªÄã¸Ò½øÈ¥ £¬×¼ÄÜÓöµ½ÈȰ®ÎÄÒÕ¡¢¸ã´´×÷µÄÄêÇáÈË¡£ÁíÓÐ £¬ÄÇЩÏïβµÄÀÏÎݸijɵÄÊé°É £¬²ÅÊǺóϪ½ÖµÄ¡°ÄêÇá»ê¡±¡£

ºóϪ½ÖµÄ¡°¶Ôζ¡± £¬ÀϹðÁÖÈË¿´µÃ͸¡£

ÕÕÎÒ¿´À´à£ £¬ºóϪ½ÖÕâµØ·½¾ÍÏñÎÒÃǹðÁÖµÄÏï×ÓÎÄ»¯¡£Äã˵ÎÒÃÇÍõ³ÇÄÇÍ·µÄÏï×Ó £¬ÊDz»ÊÇÒ²ÓеãÕâ¸öζµÀ£¿Ïï×ÓÍ·Êdz£¼ûµÄÓοÍ·Ïß £¬Ïï×Óβȴ²Ø×ŹðÁÖÍâµØÈ˵ÄÑÌ»ðÆø £¬Ïñɶ×ÓÓͲè�¡¢ÀÏʽÃ×·Ûµê £¬ÕâЩµØ¸Õ¸ÕÓС°¶Ôζ¡±¡£

Ïà¹ØÍ¼Æ¬

ÏÃÃŵĺóϪ½ÖÒ²ÊÇí¥×Ó £¬³õ¿´ÊǸöÀÏ½Ö £¬ÊµÔòÄêÇáÈ˺ÍÀÏÎÄ»¯½»Ö¯µÃÂùÓÐÒâ˼¡£ÄãÒªÊÇÖ»¿´Íâò £¬¿Ï¶¨¾õµÃËüûµÃɶ×Ó»îÁ¦£»µ«Èç¹ûÄãÓÐÐÄ £¬ÉîÈëÒ»µãÈ¥ÌåÑé £¬ÄÇЩÄêÇáÈËÔÚÀϽÖÀïÍ·Íæ³öÀ´µÄл¨Ñù £¬ÕæµÎÊÇÂùÓп´Í·¡£

Ò»¸öС¹Å×Ð £¬½²ºóϪ½ÖµÄ¡°ÄêÇá»ê¡±¡£

£¨¿ÚÓïÌ壩ÄÇ¿­ÎÒ³ÔÍêÍí·¹ £¬¾ÍÏëÈ¥Ïï×ÓÀïÍ··¢»áñ² £¬Ã»ÔøÏë×ßµ½Ïï×Óβ £¬¿´µ½Ò»¼ÒÃÅÁ³Ã»ÆðÑ۵Ŀ§·È¹Ý¡£ÀïÍ·×øÆð¼¸¸öÄêÇáÈË £¬×À×ÓÉϰÚ×ÅÒ»¶Ñ»­±Ê¡¢»­Ö½ £¬»¹ÔÚ³¶°å·½²ËûÃǵĴ´Òâ¡£ÎÒ¾Í×øÏµãÁËÒ»±­¿§·È £¬ÌýËûÃÇÁÄ £¬²ÅÏþµÃÕâ¼ÒµêÊÇÒ»¸öÄêÇá»­¼Ò¿ªµÄ £¬×¨ÃŸøÎÄÒÕÇàÄê¸ã½»Á÷µÄ¡£ÄǸö¿§·ÈÏãζƮ³öÀ´ £¬ÕæµÎÊÇÏãÍêÁË¡£

£¨×ª»ØÆÕͨ»°£©ÄÇÒ»¿ÌÎҾ;õµÃ £¬ºóϪ½Ö²Ø×ŵÄÕâЩСµê £¬²ÅÊÇÄêÇáÈ˵ġ°Éú·¡±¡£ÄãÖ»Òª¶àתת £¬¶à·¢ñ² £¬Ò»¶¨ÄÜ·¢Ã÷ËüµÄÁíÒ»Ãæ¡£


×ܽáÒ»¾ä £¬ÁôµãÏëͷ࣡£

Äã¿ÉÄÜ»áÎÊÎÒ £¬ÚÀ £¬ÄǺóϪ½Ö¾¿¾¹Êʲ»ÊʺÏÄêÇáÈ˺ã¾Ã´ý£¿ÎÒ¸úÄ㽲࣠£¬Õâ¾ÍµÃ¿´ÄãÊÇɶ×ÓÈËÁË¡£Ï²»¶Âý½Ú×ࡢϲ»¶ÎÄÒÕÆøÏ¢µÄ £¬ºóϪ½Ö¼òÖ±¾ÍÊÇÌìÌ㻵«ÒªÊÇͼ¿ì»î¡¢Í¼ÈÈÄÖ £¬ÄÇ¿ÉÄÜÕÕ¾ÉÒª¿Ë´ó½ÖÉÏÕÒÕÒ¸üºÏÊÊ¡£

ºáÊúÂï £¬ÄêÇáÈ˵ÄÉú·ÔÚÄÄÀï £¬ÊÇÒª×Ô¼ºÈ¥×ßµÄ £¬ºóϪ½ÖÖ»ÊÇÒ»¸ö¡Î¿½å¼Ãյס±¡£Äã½²ÊÇûÊÇ¿©£¿

±êÇ©

#ºóϪ½Ö #ÏÃÃÅÀÏ½Ö #ÄêÇáÈËÉú· #¹ðÁÖÏï×ÓÎÄ»¯ #ÎÄÒÕÇàÄêÃØÃÜ»ùµØ

Ïà¹ØÍ¼Æ¬

¡¶ÉîÛÚ×ÆË¸Ð¡Ïï×Ó¡·

FDA ÔÚÖ¸µ¼ÎļþÖÐÃ÷È·Ö¸³ö £¬Éê°ì·½ÔÚ¿¼ÂDZ´Ò¶Ë¹Éè¼ÆÊ±Ó¦¾¡ÔçÓë¼à¹Ü²¿·ÖÏàͬ £¬ÐëҪʱ¿Éͨ¹ý¡°ÅÓ´óÁ¢ÒìÊÔÑéÉè¼ÆÅä¶Ô¼¯»áÏîÄ¿¡±£¨Complex Innovative Trial Design Paired Meeting Program£©»ñµÃÌØÁíÍâ¼¼ÊõÖ¸µ¼¡£ÕâÒâζ×Å £¬¾¡¹ÜÕþ²ß´óÃÅÒѾ­·­¿ª £¬µ«¾ßÌåÄÜ×ß¶àÔ¶ £¬ÈÔÈ¡¾öÓÚ¼à¹Ü·½ÓëÉê°ì·½µÄ¹²Ê¶Ë®Æ½ºÍ°¸Àý»ýÀÛ¡£

¡¶ÇåÔ¶Áµ°®Ð¡Ïï×î×ÅÃûµÄÈý¸öµØ·½¡·

4£® СÃׯû³µÒÀÈ»ºÜÊÇÖØÊÓÖÇÄܼÝÊ»ÁìÓòµÄÍŶӽ¨Éè¡¢È˲ÅͶÈë £¬Ä¿Ç°Ð¡Ãׯû³µÖÇÄܼÝÊ»ÍŶÓÁè¼Ý1800ÈË £¬²¢ÉèÁ¢Á˱±¾©¡¢ÉϺ£¡¢Î人Èý´óÑз¢ÖÐÐÄ¡£×î½üÍÆË͵ÄСÃ× HAD ÔöÇ¿°æ £¬Êܵ½Á˳µÖ÷ÅóÓÑÃÇµÄºÃÆÀ £¬½¹µãÊÇÒýÈë¡°Ç¿»¯Ñ§Ï°Ëã·¨¡±ºÍ¡°ÊÀ½çÄ£ÐÍ¡±¡£

¡¶¼ÃÄþÖе¹㳡¼¦Îѵĵص㡷

¡°2026ÄêA¹ÉÊг¡ÓÐÍû´Ó½á¹¹Å£×ªÏòÈ«ÃæÅ£ £¬ÌرðÊÇǰÆÚÖÍÕǵÄһЩÓÅÖÊÁúÍ·¹ÉÓпÉÄÜ»áÓ­À´¹ÀÖµÉÏÉýµÄʱ»ú £¬°üÀ¨Ïû·Ñ°×Âí¹É £¬ÐÂÄÜÔ´ÁúÍ·¹É £¬ÒÔ¼°¾ü¹¤¡¢ÓÐÉ«µÈ¸ü¶àµÄ°å¿é»áʵÏÖÂÖÕÇ £¬¶ø²»ÊÇÏñ2025ÄêÄÇÑù¿Æ¼¼¹ÉÒ»Ö¦¶ÀÐã £¬ÆäËû°å¿éûÓÐÌåÏÖ¡£¡±ÑîµÂÁúÆÊÎö˵¡£

ÍøÕ¾µØÍ¼